| Bioactivity | C17 Globotriaosylceramide (d18:1/17:0) is a sphygosine lipid that can be used to quantify Globotriaosylceramide in plasma and urine of patients with Fabry disease by gas chromatography-mass spectrometry (GC-MS)[1]. |
| CAS | 536745-81-0 |
| Formula | C53H99NO18 |
| Molar Mass | 1038.35 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Provençal P, et al. Relative distribution of Gb3 isoforms/analogs in NOD/SCID/Fabry mice tissues determined by tandem mass spectrometry. Bioanalysis. 2016 Sep;8(17):1793-807. |
C17 Globotriaosylceramide (d18:1/17:0)
CAS: 536745-81-0 F: C53H99NO18 W: 1038.35
C17 Globotriaosylceramide (d18:1/17:0) is a sphygosine lipid that can be used to quantify Globotriaosylceramide in plasm
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.